AG THERAPY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AG THERAPY
Largest movements
- Cash -€6,197
down €6,197 (-97.9%), from €6,334 to €136
mainly Receivables within one year (-€3,646) and Net result for the year (-€2,851)
- Receivables within one year +€3,646
new in 2025: €3,646
- Tangible fixed assets -€300
down €300 (-23.6%), from €1,270 to €970
- Profit (loss) carried forward -€2,851
down €2,851, from €306 to -€2,546
- Gross operating margin -€11,196
down €11,196, from €8,836 to -€2,359
- Depreciation -€2,448
down €2,448 (-89.1%), from €2,748 to €300
- Taxes -€1,798
no longer reported in 2025 (was €1,798)
- Other operating charges -€280
down €280 (-72.3%), from €387 to €107
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,603 | €4,752 | -€2,851 | -37.5% |
| Fixed assets | 21/28 | €1,270 | €970 | -€300 | -23.6% |
| Tangible fixed assets | 22/27 | €1,270 | €970 | -€300 | -23.6% |
| Furniture and vehicles | 24 | €1,270 | €970 | -€300 | -23.6% |
| Current assets | 29/58 | €6,334 | €3,782 | -€2,551 | -40.3% |
| Amounts receivable within one year | 40/41 | - | €3,646 | +€3,646 | |
| Other amounts receivable | 41 | - | €3,646 | +€3,646 | |
| Cash at bank and in hand | 54/58 | €6,334 | €136 | -€6,197 | -97.9% |
| Total equity and liabilities | 10/49 | €7,603 | €4,752 | -€2,851 | -37.5% |
| Equity | 10/15 | €5,806 | €2,954 | -€2,851 | -49.1% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €3,500 | €3,500 | = | 0.0% |
| Distributable reserves | 133 | €3,500 | €3,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €306 | -€2,546 | -€2,851 | |
| Amounts payable | 17/49 | €1,798 | €1,798 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,798 | €1,798 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €1,798 | €1,798 | = | 0.0% |
| Taxes | 450/3 | €1,798 | €1,798 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,748 | €300 | -€2,448 | -89.1% |
| Other operating charges | 640/8 | €387 | €107 | -€280 | -72.3% |
| Gross operating margin | 9900 | €8,836 | -€2,359 | -€11,196 | |
| Operating profit (loss) | 9901 | €5,701 | -€2,767 | -€8,468 | |
| Financial charges | 65/66B | €98 | €85 | -€13 | -13.1% |
| Recurring financial charges | 65 | €98 | €85 | -€13 | -13.1% |
| Profit (loss) for the period before taxes | 9903 | €5,603 | -€2,851 | -€8,455 | |
| Income taxes | 67/77 | €1,798 | - | -€1,798 | |
| Profit (loss) for the period | 9904 | €3,806 | -€2,851 | -€6,657 | |
| Profit (loss) for the period to be appropriated | 9905 | €3,806 | -€2,851 | -€6,657 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.